Moreover, sorafenib‐induced suppression of HCC progression appears to be mediated, at least in part, by upregulating SERPING1 expression and activating the p‐ERK‐MMP‐2‐MMP‐9 cascade. Here, MMP9 is linked to hepatocellular carcinoma.